Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a diabetic foot ulcer or a venous leg ulcer that has not reduced in size by at least 50% after 4 weeks of standard treatments, such as wound cleaning, removal of dead tissue, infection control, blood sugar management (for diabetic foot ulcers), compression therapy (for venous leg ulcers), or moist wound dressings.
Who may not be able to join:
- People who have an active or hidden infection in the affected area.
- People who have health conditions that would make the risk of complications after a procedure too high.
- People whose ulcer cannot be adequately cleaned of dead or damaged tissue (a process called debridement).
- People whose ulcer, after cleaning, shows signs of continued tissue death early on due to poor blood flow to the wound area.
- People whose wound involves multiple ulcer areas with exposed bone and no blood flow in the wound bed.
- People who have had an allergic reaction to a type of antibiotic called aminoglycosides (such as gentamicin or streptomycin), as these are used during the manufacturing process of the treatment being studied.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: David Mason, MD, MiMedx Group, Inc.
Phone: 770-651-9100
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Efficacy Endpoint: Healing of Ulcers at 4 Weeks, 8 Weeks, and 12 Weeks; Safety Endpoint: Incidence of Adverse Events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.